Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 13 | 2025 | 321 | 5.890 |
Why?
|
| Plaque, Atherosclerotic | 7 | 2023 | 154 | 2.740 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2025 | 3863 | 2.360 |
Why?
|
| Leg | 7 | 2025 | 142 | 2.020 |
Why?
|
| Carotid Stenosis | 3 | 2022 | 135 | 1.700 |
Why?
|
| Muscle, Skeletal | 8 | 2025 | 1041 | 1.570 |
Why?
|
| Carotid Artery Diseases | 6 | 2022 | 148 | 1.520 |
Why?
|
| Diabetes Mellitus | 4 | 2023 | 937 | 1.420 |
Why?
|
| Regional Blood Flow | 3 | 2024 | 217 | 1.300 |
Why?
|
| Femoral Artery | 4 | 2023 | 192 | 1.090 |
Why?
|
| Calcinosis | 4 | 2014 | 190 | 1.020 |
Why?
|
| Thigh | 3 | 2022 | 52 | 0.730 |
Why?
|
| Machine Learning | 1 | 2025 | 345 | 0.700 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2010 | 53 | 0.680 |
Why?
|
| Perfusion | 2 | 2023 | 210 | 0.640 |
Why?
|
| Blood Flow Velocity | 2 | 2020 | 450 | 0.630 |
Why?
|
| Microvessels | 1 | 2019 | 62 | 0.610 |
Why?
|
| Endarterectomy, Carotid | 3 | 2016 | 95 | 0.600 |
Why?
|
| Walking | 1 | 2020 | 233 | 0.590 |
Why?
|
| Algorithms | 6 | 2016 | 1730 | 0.550 |
Why?
|
| Reproducibility of Results | 11 | 2022 | 3046 | 0.550 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2019 | 616 | 0.530 |
Why?
|
| Coronary Disease | 1 | 2021 | 685 | 0.520 |
Why?
|
| Femoral Vein | 1 | 2016 | 49 | 0.500 |
Why?
|
| Vascular Calcification | 1 | 2016 | 69 | 0.460 |
Why?
|
| Coronary Artery Disease | 3 | 2010 | 896 | 0.410 |
Why?
|
| Stroke | 1 | 2022 | 1079 | 0.410 |
Why?
|
| Intermittent Claudication | 2 | 2023 | 60 | 0.400 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 1068 | 0.400 |
Why?
|
| Lipids | 2 | 2013 | 565 | 0.390 |
Why?
|
| Contrast Media | 4 | 2025 | 517 | 0.390 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2010 | 2191 | 0.390 |
Why?
|
| Pattern Recognition, Automated | 2 | 2011 | 49 | 0.370 |
Why?
|
| Muscles | 1 | 2011 | 255 | 0.350 |
Why?
|
| Humans | 28 | 2025 | 133271 | 0.330 |
Why?
|
| Case-Control Studies | 3 | 2025 | 3411 | 0.310 |
Why?
|
| Ankle Brachial Index | 2 | 2020 | 45 | 0.300 |
Why?
|
| Aged | 8 | 2025 | 21476 | 0.290 |
Why?
|
| Carotid Arteries | 2 | 2022 | 144 | 0.290 |
Why?
|
| Sensitivity and Specificity | 6 | 2014 | 2141 | 0.280 |
Why?
|
| Male | 18 | 2025 | 65523 | 0.260 |
Why?
|
| Female | 15 | 2025 | 71439 | 0.240 |
Why?
|
| Coronary Angiography | 1 | 2008 | 485 | 0.230 |
Why?
|
| Middle Aged | 9 | 2025 | 28952 | 0.230 |
Why?
|
| Artificial Intelligence | 1 | 2008 | 297 | 0.210 |
Why?
|
| Vascular Stiffness | 2 | 2015 | 80 | 0.190 |
Why?
|
| Myocardium | 2 | 2019 | 923 | 0.180 |
Why?
|
| Double-Blind Method | 2 | 2016 | 1660 | 0.170 |
Why?
|
| Lower Extremity | 1 | 2022 | 188 | 0.170 |
Why?
|
| Myocardial Revascularization | 1 | 2021 | 107 | 0.170 |
Why?
|
| Exercise Test | 1 | 2020 | 263 | 0.160 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 3105 | 0.160 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 170 | 0.150 |
Why?
|
| X-Ray Microtomography | 2 | 2015 | 95 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 237 | 0.130 |
Why?
|
| Walk Test | 1 | 2016 | 29 | 0.130 |
Why?
|
| Blood Volume | 1 | 2016 | 82 | 0.120 |
Why?
|
| Hyperemia | 1 | 2016 | 35 | 0.120 |
Why?
|
| Carotid Artery, Internal | 1 | 2015 | 65 | 0.120 |
Why?
|
| Postprandial Period | 1 | 2015 | 91 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 510 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 68 | 0.110 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 169 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2015 | 999 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 186 | 0.110 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 233 | 0.110 |
Why?
|
| Arteries | 1 | 2015 | 228 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 309 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 199 | 0.100 |
Why?
|
| Niacin | 1 | 2013 | 59 | 0.100 |
Why?
|
| Azetidines | 1 | 2013 | 64 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2015 | 298 | 0.100 |
Why?
|
| Automation, Laboratory | 2 | 2010 | 15 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2015 | 453 | 0.100 |
Why?
|
| Simvastatin | 1 | 2013 | 77 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 509 | 0.100 |
Why?
|
| Ezetimibe | 1 | 2013 | 98 | 0.100 |
Why?
|
| Mitochondria, Heart | 1 | 2013 | 55 | 0.100 |
Why?
|
| Hyperinsulinism | 1 | 2013 | 71 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 398 | 0.100 |
Why?
|
| Incidence | 1 | 2021 | 3391 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 543 | 0.100 |
Why?
|
| Lipoproteins | 1 | 2013 | 191 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2015 | 509 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2015 | 289 | 0.090 |
Why?
|
| Normal Distribution | 1 | 2011 | 20 | 0.090 |
Why?
|
| Insulin Resistance | 2 | 2015 | 700 | 0.090 |
Why?
|
| Automation | 1 | 2011 | 63 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 2288 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 69 | 0.090 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2013 | 141 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1730 | 0.080 |
Why?
|
| Cholesterol | 1 | 2013 | 571 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 504 | 0.080 |
Why?
|
| Atherosclerosis | 2 | 2015 | 1002 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2023 | 13102 | 0.080 |
Why?
|
| Brain Mapping | 1 | 2011 | 405 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2011 | 500 | 0.070 |
Why?
|
| Time Factors | 2 | 2016 | 6545 | 0.070 |
Why?
|
| Glucose | 1 | 2013 | 916 | 0.070 |
Why?
|
| Inflammation | 1 | 2015 | 1557 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2008 | 173 | 0.060 |
Why?
|
| Obesity | 2 | 2015 | 2438 | 0.060 |
Why?
|
| Echocardiography | 1 | 2011 | 1127 | 0.060 |
Why?
|
| Adult | 4 | 2019 | 31650 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2014 | 5196 | 0.060 |
Why?
|
| Texas | 2 | 2010 | 3664 | 0.060 |
Why?
|
| Hypertension | 1 | 2013 | 1402 | 0.050 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2013 | 80 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1420 | 0.050 |
Why?
|
| Diet, High-Fat | 2 | 2015 | 241 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17556 | 0.050 |
Why?
|
| Risk Factors | 1 | 2016 | 10956 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 2092 | 0.040 |
Why?
|
| Gadolinium DTPA | 1 | 2019 | 49 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2019 | 86 | 0.040 |
Why?
|
| Lung Diseases, Fungal | 1 | 1999 | 32 | 0.040 |
Why?
|
| Brain | 1 | 2011 | 3223 | 0.040 |
Why?
|
| Histoplasmosis | 1 | 1999 | 49 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2015 | 211 | 0.040 |
Why?
|
| Fibrosis | 1 | 2019 | 428 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 1999 | 200 | 0.030 |
Why?
|
| Age Factors | 2 | 2015 | 2954 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 4823 | 0.030 |
Why?
|
| Absorption, Physicochemical | 1 | 2015 | 3 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2015 | 58 | 0.030 |
Why?
|
| Pulse Wave Analysis | 1 | 2015 | 51 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 153 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2015 | 185 | 0.030 |
Why?
|
| Palmitoylcarnitine | 1 | 2013 | 4 | 0.030 |
Why?
|
| Succinic Acid | 1 | 2013 | 14 | 0.030 |
Why?
|
| Streptozocin | 1 | 2013 | 28 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2013 | 103 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 464 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2013 | 209 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 708 | 0.020 |
Why?
|
| Radio Waves | 1 | 2011 | 8 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 256 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2013 | 215 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2011 | 107 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 115 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1136 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1468 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2011 | 142 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5436 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 5042 | 0.020 |
Why?
|
| Knee Joint | 1 | 2011 | 171 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2013 | 3978 | 0.020 |
Why?
|
| Equipment Design | 1 | 2011 | 604 | 0.020 |
Why?
|
| Mice | 3 | 2015 | 18929 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 492 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 317 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6582 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 1245 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 823 | 0.020 |
Why?
|
| Animals | 3 | 2015 | 36195 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4755 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 3719 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 9925 | 0.010 |
Why?
|
| Histoplasma | 1 | 1999 | 31 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1999 | 60 | 0.010 |
Why?
|
| Lymphopenia | 1 | 1999 | 40 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1999 | 125 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1999 | 155 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 286 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1999 | 780 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1999 | 536 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1999 | 684 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1999 | 542 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1999 | 1584 | 0.010 |
Why?
|